Literature DB >> 18945841

Molecular epidemiology and phylogenetic distribution of the Escherichia coli pks genomic island.

James R Johnson1, Brian Johnston, Michael A Kuskowski, Jean-Philippe Nougayrede, Eric Oswald.   

Abstract

Epidemiological and phylogenetic associations of the pks genomic island of extraintestinal pathogenic Escherichia coli (ExPEC), which encodes the genotoxin colibactin, are incompletely defined. clbB and clbN (as markers for the 5' and 3' regions of the pks island, respectively), clbA and clbQ (as supplemental pks island markers), and 12 other putative ExPEC virulence genes were newly sought by PCR among 131 published E. coli isolates from hospitalized veterans (62 blood isolates and 69 fecal isolates). Blood and fecal isolates and clbB-positive and -negative isolates were compared for 66 newly and previously assessed traits. Among the 14 newly sought traits, clbB and clbN (colibactin polyketide synthesis system), hra (heat-resistant agglutinin), and vat (vacuolating toxin) were significantly associated with bacteremia. clbB and clbN identified a subset within phylogenetic group B2 with extremely high virulence scores and a high proportion of blood isolates. However, by multivariable analysis, other traits were more predictive of blood source than clbB and clbN were; indeed, among the newly sought traits, only pic significantly predicted bacteremia (negative association). By correspondence analysis, clbB and clbN were closely associated with group B2 and multiple B2-associated traits; by principal coordinate analysis, clbB and clbN partitioned the data set better than did blood versus fecal source. Thus, the pks island was significantly associated with bacteremia, multiple ExPEC-associated virulence genes, and group B2, and within group B2, it identified an especially high-virulence subset. This extends previous work regarding the pks island and supports investigation of the colibactin system as a potential therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18945841      PMCID: PMC2593299          DOI: 10.1128/JCM.00949-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  25 in total

Review 1.  Correspondence analysis in medical research.

Authors:  M Greenacre
Journal:  Stat Methods Med Res       Date:  1992       Impact factor: 3.021

2.  Identification of two previously unrecognized genes (guaA and argC) important for uropathogenesis.

Authors:  T A Russo; S T Jodush; J J Brown; J R Johnson
Journal:  Mol Microbiol       Date:  1996-10       Impact factor: 3.501

3.  P fimbriae, capsule and aerobactin characterize colonic resident Escherichia coli.

Authors:  F Nowrouzian; I Adlerberth; A E Wold
Journal:  Epidemiol Infect       Date:  2001-02       Impact factor: 2.451

4.  Analysis of the F antigen-specific papA alleles of extraintestinal pathogenic Escherichia coli using a novel multiplex PCR-based assay.

Authors:  J R Johnson; A L Stell; F Scheutz; T T O'Bryan; T A Russo; U B Carlino; C Fasching; J Kavle; L Van Dijk; W Gaastra
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

5.  The occurrence of ambient temperature-regulated adhesins, curli, and the temperature-sensitive hemagglutinin tsh among avian Escherichia coli.

Authors:  J J Maurer; T P Brown; W L Steffens; S G Thayer
Journal:  Avian Dis       Date:  1998 Jan-Mar       Impact factor: 1.577

6.  Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise.

Authors:  J R Johnson; A L Stell
Journal:  J Infect Dis       Date:  2000-01       Impact factor: 5.226

Review 7.  Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem.

Authors:  Thomas A Russo; James R Johnson
Journal:  Microbes Infect       Date:  2003-04       Impact factor: 2.700

8.  The pathogenicity island-associated K15 capsule determinant exhibits a novel genetic structure and correlates with virulence in uropathogenic Escherichia coli strain 536.

Authors:  György Schneider; Ulrich Dobrindt; Holger Brüggemann; Gábor Nagy; Britta Janke; Gabriele Blum-Oehler; Carmen Buchrieser; Gerhard Gottschalk; Levente Emödy; Jörg Hacker
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

9.  Extraintestinal pathogenic Escherichia coli as a cause of invasive nonurinary infections.

Authors:  James R Johnson; Abby Gajewski; Alan J Lesse; Thomas A Russo
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

10.  The homogeneity of the faecal coliform flora of normal school-girls, characterized by serological and biochemical properties.

Authors:  G Lidin-Janson; B Kaijser; K Lincoln; S Olling; H Wedel
Journal:  Med Microbiol Immunol       Date:  1978       Impact factor: 3.402

View more
  70 in total

1.  Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells.

Authors:  Gabriel Cuevas-Ramos; Claude R Petit; Ingrid Marcq; Michèle Boury; Eric Oswald; Jean-Philippe Nougayrède
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

2.  Colonization with Escherichia coli Strains among Female Sex Partners of Men with Febrile Urinary Tract Infection.

Authors:  Peter Ulleryd; Torsten Sandberg; Flemming Scheutz; Connie Clabots; Brian D Johnston; Paul Thuras; James R Johnson
Journal:  J Clin Microbiol       Date:  2015-04-01       Impact factor: 5.948

3.  Virulence of Escherichia coli clinical isolates in a murine sepsis model in relation to sequence type ST131 status, fluoroquinolone resistance, and virulence genotype.

Authors:  James R Johnson; Stephen B Porter; George Zhanel; Michael A Kuskowski; Erick Denamur
Journal:  Infect Immun       Date:  2012-02-06       Impact factor: 3.441

4.  Prevalence of Escherichia coli Carrying pks Islands in Bacteremia Patients.

Authors:  Eunyoung Lee; Yangsoon Lee
Journal:  Ann Lab Med       Date:  2018-05       Impact factor: 3.464

Review 5.  Oral and intestinal bacterial exotoxins: Potential linked to carcinogenesis.

Authors:  Matthew Silbergleit; Adrian A Vasquez; Carol J Miller; Jun Sun; Ikuko Kato
Journal:  Prog Mol Biol Transl Sci       Date:  2020-04-09       Impact factor: 3.622

6.  Model Colibactins Exhibit Human Cell Genotoxicity in the Absence of Host Bacteria.

Authors:  Emilee E Shine; Mengzhao Xue; Jaymin R Patel; Alan R Healy; Yulia V Surovtseva; Seth B Herzon; Jason M Crawford
Journal:  ACS Chem Biol       Date:  2018-11-20       Impact factor: 5.100

7.  Inhibitor-resistant TEM- and OXA-1-producing Escherichia coli isolates resistant to amoxicillin-clavulanate are more clonal and possess lower virulence gene content than susceptible clinical isolates.

Authors:  Jesús Oteo; Juan José González-López; Adriana Ortega; J Natalia Quintero-Zárate; Germán Bou; Emilia Cercenado; María Carmen Conejo; Luis Martínez-Martínez; Ferran Navarro; Antonio Oliver; Rosa M Bartolomé; José Campos
Journal:  Antimicrob Agents Chemother       Date:  2014-04-28       Impact factor: 5.191

8.  The Genotoxin Colibactin Is a Determinant of Virulence in Escherichia coli K1 Experimental Neonatal Systemic Infection.

Authors:  Alex J McCarthy; Patricia Martin; Emilie Cloup; Richard A Stabler; Eric Oswald; Peter W Taylor
Journal:  Infect Immun       Date:  2015-07-06       Impact factor: 3.441

9.  Characterization of Ciprofloxacin-Resistant and Ciprofloxacin-Susceptible Uropathogenic Escherichia coli Obtained from Patients with Gynecological Cancer.

Authors:  Muniqui S Capett; Patricia Vollú-Silva; Vanessa A Melchiades; Luciana C Bokehi; Fernanda M Araújo; Ianick Souto Martins; Felipe P G Neves; Alice G M Gonzalez; Eric Oswald; Geraldo R de Paula; Lenise A Teixeira
Journal:  Curr Microbiol       Date:  2016-07-26       Impact factor: 2.188

10.  Sharing of Escherichia coli sequence type ST131 and other multidrug-resistant and Urovirulent E. coli strains among dogs and cats within a household.

Authors:  James R Johnson; Sybille Miller; Brian Johnston; Connie Clabots; Chitrita Debroy
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.